2 studies found for:    mdx-1106 hcv
Show Display Options
Rank Status Study
1 Completed A Study of MDX-1106 to Treat Patients With Hepatitis C Infection
Condition: Hepatitis C
Interventions: Drug: MDX1106-02;   Drug: Placebo
2 Recruiting Dose Escalation Study of Nivolumab (Anti-PD-1; BMS-936558; ONO-4538) in Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC) With or Without Chronic Viral Hepatitis
Condition: Hepatocellular Carcinoma
Intervention: Biological: Nivolumab

Indicates status has not been verified in more than two years